U.S. Markets open in 7 hrs, 28 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,384.21 | 152.25 | 1.36% |
| NASDAQ | 2,294.44 | 51.12 | 2.28% |
| S&P 500 | 1,273.70 | 21.39 | 1.71% |
| Day Low 11:10 AM EDT | 1.15 | |
|---|---|---|
| Day High 10:27 AM EDT | 1.2276 |
|
| Range | 0.08 | |
| Volume | 23,605 | |
| 30-Day Avg. Vol. | 30,000 |
|
| Difference | -21.32% | |
| Market Cap. | 36.66 M | |
| Change | -3,081 | |
| Shares Out. | 30.8 M | |
| Percent Traded | 0.08% | |
| Revenue | — | |
| Earnings | — | |
| EPS (TTM) | -0.30 |
| 52-Wk Low 4/18/08 | 0.8101 | |
|---|---|---|
| 52-Wk High 7/12/07 | 2.78 |
|
| Range | 1.97 | |
| Prev. Close 7/7/08 | 1.19 | |
| Today's Open | 1.18 | |
| Change | -0.84% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | 0.8345 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -1.00 |
A.P. Pharma wants to hit you where it hurts. The firm develops bioerodible polymers for injectable and implantable drug delivery. Its Biochronomer technology delivers medication directly to the site where ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.175 12/31/07 | -0.25 12/31/07 |
-0.075
Missed
|
| Last Quarter | -0.215 3/31/08 | -0.22 3/31/08 |
-0.005
Missed
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
